muramylnac-ala-isogln-lys-tripeptide has been researched along with Disease Models, Animal in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davey, MP; Flavell, RA; Jann, MM; Kobayashi, K; Martin, TM; Planck, SR; Rosenbaum, JT; Rosenzweig, HL | 1 |
Anke, A; Brunner, P; Izbicki, JR; Leinisch, E; Lüttiken, R; Raedler, C; Ruckdeschel, G; Schweiberer, L; Siebeck, M; Wilker, DK | 1 |
2 other study(ies) available for muramylnac-ala-isogln-lys-tripeptide and Disease Models, Animal
Article | Year |
---|---|
NOD2, the gene responsible for familial granulomatous uveitis, in a mouse model of uveitis.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Animals; Arthritis; Dermatitis; Disease Models, Animal; Female; Granuloma; Iris; L-Selectin; Leukocytes; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, Knockout; Nod2 Signaling Adaptor Protein; Uveitis | 2008 |
Beneficial effect of liposome-encapsulated muramyl tripeptide in experimental septicemia in a porcine model.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Animals; Disease Models, Animal; Female; Leukocyte Count; Liposomes; Monocytes; Pneumococcal Infections; Sepsis; Survival; Swine; Swine, Miniature | 1991 |